Questions: Vitamin D: Intestinal Absorption, Calcium Homeostasis, and Bone Health

Question 1

A patient with chronic kidney disease has low serum calcitriol despite normal dietary vitamin D intake and adequate sun exposure. Which best explains this?

• A. The liver cannot hydroxylate cholecalciferol to calcidiol in CKD patients
• B. The kidney cannot perform the second hydroxylation step to produce active calcitriol
• C. PTH is suppressed in CKD, preventing vitamin D activation
• D. Intestinal VDR expression is downregulated in kidney disease, reducing calcitriol responsiveness

Answer: (B)

The critical second hydroxylation step — converting calcidiol (the storage form) to calcitriol (active vitamin D) — occurs in the kidney via 1α-hydroxylase. In CKD, this step fails even when sun exposure and hepatic hydroxylation are normal. This is why renal failure patients require supplemental calcitriol or analogs, not just ordinary vitamin D supplements. Option C reverses the actual relationship: low calcitriol causes high PTH (secondary hyperparathyroidism), not the other way around. PTH normally stimulates 1α-hydroxylase — if PTH were suppressed, calcitriol would fall further.

Question 2

A patient deficient in vitamin D takes calcium supplements but no vitamin D. Which outcome best describes what actually happens?

• A. Calcium absorption increases because more dietary calcium is now available in the gut
• B. Bone mineralization normalizes as serum calcium rises from the higher dietary intake
• C. PTH remains elevated because intestinal calcium absorption stays low without calcitriol
• D. Symptoms of deficiency resolve because calcium homeostasis is restored through diet

Answer: (C)

Calcitriol must upregulate TRPV6 channels and calbindin in enterocytes before active transcellular calcium absorption can occur. Without calcitriol, gut absorption stays at the passive diffusion level (~10–15%) regardless of dietary calcium load. Serum calcium remains low, PTH stays elevated, and bone continues to be resorbed to maintain blood calcium. Calcium supplements without calcitriol cannot restore the active absorption mechanism — the problem is not the amount of calcium arriving at the gut wall, but the absence of the transport machinery to bring it across.

Question 3

Calcitriol promotes bone mineralization by directly stimulating osteoblasts to deposit calcium into bone matrix.

• T. True
• F. False

Answer: False

Calcitriol does not directly deposit calcium into bone — that is osteoblasts' job, acting on hydroxyapatite. Calcitriol's primary role is to ensure that serum calcium and phosphate concentrations remain high enough for spontaneous mineralization to occur. It accomplishes this by maximizing intestinal calcium absorption. The bone mineralization failure in vitamin D deficiency is indirect: low calcitriol → poor absorption → low serum calcium → secondary hyperparathyroidism → bone resorption to maintain blood calcium. The remedy is restoring the mineral supply, not directly stimulating osteoblasts.

Question 4

In vitamin D deficiency, the body's attempt to maintain serum calcium ultimately leads to net loss of bone mineral.

• T. True
• F. False

Answer: True

When calcitriol is insufficient, intestinal calcium absorption falls to ~10–15%. Serum calcium begins to drop, triggering PTH secretion (secondary hyperparathyroidism). PTH maintains serum calcium by stimulating osteoclast-mediated bone resorption — using bone as a calcium reservoir of last resort. Bone is stripped to keep blood calcium in the life-sustaining range. The cost is progressive demineralization: rickets in children (soft, deformable growing bone), osteomalacia in adults (inadequately mineralized bone matrix that is soft and painful).

Question 5

Explain why a patient with end-stage renal disease would develop bone disease even if they eat a diet rich in calcium and dairy.

Model answer: In end-stage renal disease, the kidney cannot perform the second hydroxylation step (converting calcidiol to calcitriol via 1α-hydroxylase). Without calcitriol, only ~10–15% of dietary calcium is passively absorbed rather than the 30–40% enabled by active transcellular transport. Low absorption leads to low serum calcium, which triggers secondary hyperparathyroidism; PTH then drives osteoclast-mediated bone resorption to restore blood calcium. Additionally, phosphate retention (also due to failing kidneys) creates a high phosphate-to-calcitriol ratio that further disrupts bone mineralization. Calcium supplements alone cannot solve the problem because the active absorption mechanism is absent — calcitriol or its analogs must be replaced.

The lesson generalizes: the body's ability to use dietary calcium depends entirely on adequate calcitriol, which depends on functioning kidney tubules. Dietary calcium is necessary but insufficient; the endocrine machinery to absorb and regulate it must also be intact. This is why renal failure produces some of the most severe bone disease despite patients eating normally.